title: Prenatal diagnosis of genetic disease in Canada: report of a collaborative study.
abstract: A study of 1223 amniocenteses carried out during 1020 pregnancies in 990 women showed that 2nd-trimester amniocentesis at about 16 weeks' gestation is a safe, accurate and reliable procedure for the diagnosis of certain classes of genetic disease when it is monitored by ultrasound, performed by a trained obstetrician and carried out in a major health sciences centre. The percentage of fetal losses (4.7%) and neonatal deaths (0.5%) during the study was not greater than in control samples for women 35 years of age and older. The best results were obtained when needles of gauge 20 or 21 were used. The use of needles of gauge 19 or larger and more than two insertions during a single amniocentesis were associated with a significantly greater frequency of fetal loss than a second or even a third amniocentesis during the same pregnancy. For 39 fetuses (3.8%) a diagnosis of a genetic abnormality was made and 23 male fetuses were found to be potentially hemizygous for an X-linked gene. There were 51 therapeutic abortions as a result of the diagnosis. Sixty-six tests (5.4%) gave an inconclusive result and seven (0.6%) gave an erroneous diagnosis; five of the latter (two false-positives and three false-negatives) resulted from the alpha1-fetoprotein test for neural-tube defects and in two cases the sex was incorrectly determined. The frequency of all chromosome abnormalities was 1:20 when the mother's age was 40 years or more and 1:60 when the mother's age was between 35 and 39 years. When a mother had previously had a child with a chromosome abnormality the risk of recurrence of such an abnormality was 1:100 when the age of the mother was 35 years or more.
mesh_terms: D000032:Abortion, Therapeutic; D000328:Adult; D000649:Amniocentesis / Q000009:adverse effects / Q000379:methods*; D000653:Amniotic Fluid / Q000032:analysis / Q000166:cytology; D002170:Canada; D002869:Chromosome Aberrations / Q000175:diagnosis; D025063:Chromosome Disorders; D003951:Diagnostic Errors; D005260:Female; D005313:Fetal Death / Q000209:etiology; D030342:Genetic Diseases, Inborn / Q000175:diagnosis*; D006801:Humans; D007621:Karyotyping; D008423:Maternal Age; D011247:Pregnancy; D012306:Risk; D012729:Sex Chromosome Aberrations / Q000175:diagnosis; D013116:Spinal Cord / Q000002:abnormalities; D014463:Ultrasonography; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D000509:alpha-Fetoproteins